|
|
Article: NABILONE.(for managing nausea and vomiting associated with chemotherapy)(Brief Article)
- Article from:
- Chemical Market Reporter
- Article date:
- June 12, 2000
CopyrightCOPYRIGHT 2000 Schnell Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ICN Pharmaceuticals Inc. has acquired Eli Lilly & Co.'s anti-emetic drug, Cesamet (nabilone), for the Canadian market. Cesamet is indicated in Canada for ...
Related newspaper, magazine, and journal articles:
|
|
Article: MGI and Helsinn submit Aloxi sNDA.(MGI Pharma )(Brief ...
Pharma Marketletter;
May 14, 2007 ;
700+ words
... ... approved by the agency for the prevention of acute nausea and vomiting associated with initial and repeat courses of moderately- and highly ... chemotherapy and for the prevention of delayed nausea and vomiting associated with initial and repeat courses of moderately-emetogenic ...
|
|